Document is current
Any future updates will be listed below
-
Authors
Kim, Seonji
You, Seng Chan
Il Kim, Seung
Bae, Ji-Hwan
Choi, Jong-Il
Park, Sungha
- License Information
-
More Information
Article History
Received: 16 December 2025
Revised: 27 May 2026
Accepted: 5 June 2026
First Online: 17 June 2026
Compliance with ethical standards
:
: SCY reports grants from Daiichi Sankyo. He is a coinventor of granted Korean patents DP-2023-1223 and DP-2023-0920 and has pending Patent Applications DP-2024-0909, DP-2024-0908, DP-2022-1658, DP-2022-1478, and DP-2022-1365, unrelated to the current work. SCY is the Chief Executive Officer of PHI Digital Healthcare. J-IC received consulting, speaker, or teaching fees or honoraria from Abbott, Biosense Wester Inc, Boehringer Ingelheim, Chong Kun Dang, Daewoong Pharmaceutical Co., Ltd., Daiichi Sankyo, Hanmi Pharmaceutical, I.SigNal, Medtronic, Mezoo Co., Ltd., Novartis, Roche, Samjin Pharmaceutical Co., Ltd., Sanofi, Viatris, and Yuhan; research grants from Chong Kun Dang, Samjin Pharmaceutical, and Sanofi. SP received honoraria from Viatris, Organon, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, Chong Kun Dang, Handok and Daewon, a research grant from Daiichi Sankyo, consultation fee from Skylab, and stock from Mediwhale. J-HB is a full-time employee of Daiichi Sankyo Korea. The other authors report no conflicts of interest.
